Effect of Cognitive Intervention in Alzheimer's Disease (AD) on Functional Cortical Networks in fMRI
NCT ID: NCT01329601
Last Updated: 2011-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
24 participants
INTERVENTIONAL
2011-01-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Therapy of Alzheimer's Disease With Neurofeedback
NCT03070821
Cognitive Training and Brain Stimulation in Prodromal Alzheimer's Disease
NCT04265378
Enhancing Neuroplasticity and Frontal Lobe Function in Patients With Mild Alzheimer's Disease
NCT01847586
Neuropsychological and Neurophysiological Effects of Cognitive Stimulation in Patients With Alzheimer's Disease and Mild Cognitive Impairment
NCT03784183
Support Groups for Patients With Mild Cognitive Impairment and Their Partners
NCT00285753
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Involving functional imaging measures, the intervention study, an adequate platform for the detection of intervention effects on neurobiological basis using fMRI dar. Here, the cerebral blood flow in specific activation as a measure of neuronal and synaptic activity and integrity both in cross-section of a subsample of healthy elderly people studied determined and changes in cerebral activity patterns in people with severe AD, aMCI or slightly in comparison pre-/post interventions. There are detectable much earlier in the pathogenesis of functional changes as structural, using fMRI, the study is to make a significant contribution to prove whether a modular cognitive intervention altered neural and synaptic activity and whether this change is accompanied by an improvement in cognitive performance.
A complete and proven effectiveness of cognitive group training could make a significant contribution that people with MCI and severe AD easily submit their own initiative mental condition, and add itself to sustain the intellectual, emotional and social potential. As a long-term perspective, the results for the optimization of cognitive intervention programs and continue to implement the organizations of the open and contribute stationary the elderly and specialized medical facilities and other medical facilities.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive Intervention
StaCog intervention to improve cognitive performance and activities of daily living in AD and MCI
StaCog, stage specific cognitive Intervention
StaCog intervention to improve cognitive performance and activities of daily living in AD and MCI
Booklet-based training
Home based training of episodic memory using paper-pencil exercizes
booklet based training
Home based training of episodic memory using paper-pencil exercizes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
StaCog, stage specific cognitive Intervention
StaCog intervention to improve cognitive performance and activities of daily living in AD and MCI
booklet based training
Home based training of episodic memory using paper-pencil exercizes
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* severe visual and acoustic impairment
* severe physical impairments
* known malignancy
* laboratory elevated inflammatory markers (ESR, CRP, leukocytes)
* stroke
* brain trauma
* epilepsy
* previous participation in a memory training
* patients receiving drug treatment (antidepressants, neuroleptics, anti-dementia, other brain performance enhancing drugs) at least three months prior to study initiation for the duration of the project are at a stable dosage
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DZNE, German Center for Neurodegenerative Disorders, Germany
UNKNOWN
University of Rostock
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Psychiatry, University Rostock
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stefan J. Teipel, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Rostock
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Psychiatry, University of Rostock
Rostock, Mecklenburg-Vorpommern, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Int_HRO_1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.